Short Interest in Sysmex Corporation ADR (OTCMKTS:SSMXY) Increases By 91.5%

Key Points

• Short interest in Sysmex Corporation ADR increased by 91.5% in September, rising from 5,900 shares to 11,300 shares.
• Sysmex's earnings report revealed a loss, with earnings per share at $0.05, missing estimates by $0.07, and revenue significantly below expectations at $717.09 million.
• Wall Street analysts have upgraded Sysmex's rating from a "strong sell" to a "hold," indicating a more cautious outlook on the stock.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totaling 11,300 shares, an increase of 91.5% from the August 31st total of 5,900 shares. Based on an average trading volume of 508,500 shares, the short-interest ratio is currently 0.0 days. Based on an average trading volume of 508,500 shares, the short-interest ratio is currently 0.0 days.

Sysmex Price Performance

Shares of Sysmex stock traded up $0.14 during mid-day trading on Friday, reaching $12.13. 90,831 shares of the stock traded hands, compared to its average volume of 303,722. Sysmex has a fifty-two week low of $11.93 and a fifty-two week high of $22.00. The company has a quick ratio of 2.49, a current ratio of 3.37 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $7.64 billion, a PE ratio of 24.26 and a beta of 1.16. The business has a 50-day moving average of $13.48 and a 200 day moving average of $16.18.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.07). The firm had revenue of $717.09 million during the quarter, compared to analysts' expectations of $807.27 million. Sysmex had a net margin of 9.35% and a return on equity of 10.20%. On average, analysts predict that Sysmex will post 0.57 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold".

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.